New insights into uncontrolled inflammation in COVID-19 patients
(Queen Mary University of London) Research led by Queen Mary University of London provides new insight into the mechanisms that lead to uncontrolled inflammation in COVID-19 patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

Interaction identified between SARS-CoV-2 and unusual RNA structures in human cells
(Institut Pasteur) Replication of SARS-CoV-2, the virus responsible for COVID-19, depends on a series of interactions between viral proteins and different cellular partners such as nucleic acids (DNA or RNA). Characterizing these interactions is crucial to elucidate the process of viral replication and identify new drugs for treating COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

Association between COVID-19 exposure, self-reported compliance with public health guidelines among essential employees at an institution of higher education
This study at an institution of higher education in Colorado evaluated the association between self-reported protective behaviors and how common SARS-CoV-2 infection was among essential in-person employees during the first six months of the COVID-19 pandemic in the United States. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Existing drug is shown to inhibit SARS-CoV-2 virus
(University of Chicago) A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Study links vaccine immune response to age
(Oregon Health& Science University) Older people appear to have fewer antibodies against the novel coronavirus, a new laboratory study from Oregon Health& Science University suggests. With vaccine uptake slowing in Oregon and across United States, researchers say their findings underscore the importance of promoting vaccinations in local communities. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Long COVID and severe COVID-19 infections associated with Epstein-Barr virus reactivation
(World Organization) Two recently published studies indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases. A study in Pathogens found over 73% of COVID-19 patients who were experiencing long Covid symptoms were also positive for EBV reactivation. A study in Scientific Reports by Nature found EBV reactivation was also associated with COVID-19 severity. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Heart-related test results may indicate risk of death in patients with COVID-19
(Wiley) New research published in the European Journal of Clinical Investigation identifies cardiovascular test results that might help to identify patients hospitalized with COVID-19 who face an especially high risk of dying. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

How has the COVID-19 pandemic affected our dreams?
(Wiley) The COVID-19 pandemic has strongly impacted our sleep and dream activity. In a recent study published in the Journal of Sleep Research, people had a higher number of awakenings, a harder time falling asleep, higher dream recall, and more lucid dreams during lockdown than after lockdown. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Which students are at most risk of mental health problems during COVID-19 lockdowns?
(Wiley) A new study published in JCPP Advances has compared the wellbeing of UK students who remained at home for schooling during the first lockdown period of the COVID-19 pandemic with those who accessed school in person. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

How readily does COVID-19 spread on school buses?
(Wiley) Although in-school transmission of COVID-19 among K-12 students is low when safeguards are in place, the risk of acquiring COVID-19 during school bus transportation is unclear. A study published in the Journal of School Health reports on the bus transport experience of an independent school in Virginia. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

The Lancet: 1.5 million children worldwide have lost parent, grandparent, caregiver due to COVID-19
(The Lancet) An estimated 1.5 million children worldwide have experienced the death of a parent, custodial grandparent, or other relative who cared for them, as a result of COVID-19, according to a new study published in The Lancet. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

More than 1.5M children lost a primary or secondary caregiver due to the COVID-19 pandemic
(NIH/National Institute on Drug Abuse) More than 1.5 million children around the world are estimated to have lost at least one parent, custodial grandparent, or grandparent who lived with them due to death related to COVID-19 during the first 14 months of the pandemic, according to a study published today in The Lancet. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

COVID-19 news from Annals of Internal Medicine
(American College of Physicians) 1. Currently used SARS-CoV-2 vaccines more than 95% effective in preventing confirmed infection ; 2. Having sickle cell disease quadruples risk for COVID-19-related hospitalization and doubles risk for COVID-19-related death. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

No horsing around: super-fast Hendra test developed
(University of Queensland) University of Queensland vets are diagnosing the deadly Hendra virus in horses faster than ever, developing a diagnostic point-of-care kit that can detect the pathogen in under an hour, rather than days. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa
(International Vaccine Institute) The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding of up to $12.7m to the Expanding Access and Delivery of COVID-19 Vaccines in Africa (ECOVA) consortium led by IVI to carry out clinical trials of Sinopharm's BBIBP-CorV vaccine which will support the expanded use of the vaccine on the African continent. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news